buthionine sulfoximine has been researched along with Disease Exacerbation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazaki, N; Oda, S; Tsuneyama, K; Yokoi, T | 1 |
| Alharbi, MM; Alharbi, NO; Imam, F; Nadeem, A; Siddiqui, N | 1 |
| Belizário, JE; de Andrade-Lima, LC; Garcia, CC; Menck, CF; Munford, V; Quinet, A; Rocha, CR; Vieira, DB | 1 |
| Aoyama, Y; Ishikawa, S; Izumi, T; Kishihara, J; Kosukegawa, T; Kurokawa, S; Masaki, Y; Niwano, H; Niwano, S | 1 |
| Calvin, HI; David, LL; Fu, SC; Li, W; McCormack, AL; Wu, K; Zhu, GP | 1 |
| Barber, DS; Buzescu, R; Chopra, R; Ferrante, RJ; Fox, JH; Hersch, SM; Kazantsev, A; Norflus, F; Singh, B; Swindell, MK; Zucker, B | 1 |
| Anderson, CP; Keshelava, N; Meek, WH; Reynolds, CP; Satake, N | 1 |
7 other study(ies) available for buthionine sulfoximine and Disease Exacerbation
| Article | Year |
|---|---|
Exacerbation of gefitinib-induced liver injury by glutathione reduction in mice.
Topics: Animals; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP3A; Disease Progression; Gefitinib; Glutathione; Liver; Mice, Inbred C57BL; Oxidative Stress; Protein Kinase Inhibitors | 2020 |
Acute glutathione depletion leads to enhancement of airway reactivity and inflammation via p38MAPK-iNOS pathway in allergic mice.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Buthionine Sulfoximine; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Glutamate-Cysteine Ligase; Glutathione; Inflammation; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrosation; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Signal Transduction | 2014 |
Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo.
Topics: Animals; Apoptosis; Brain Neoplasms; Buthionine Sulfoximine; Cell Line, Tumor; Cell Survival; Cisplatin; Dacarbazine; Disease Progression; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Female; Glioma; Glutathione; Humans; Mice, Nude; Temozolomide; Tumor Suppressor Protein p53 | 2014 |
Progression of ventricular remodeling and arrhythmia in the primary hyperoxidative state of glutathione-depleted rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Action Potentials; Analysis of Variance; Animals; Arrhythmias, Cardiac; Blood Pressure; Blotting, Western; Buthionine Sulfoximine; Cardiac Pacing, Artificial; Cytokines; Deoxyguanosine; Disease Models, Animal; Disease Progression; Ether-A-Go-Go Potassium Channels; Glutathione; Hydrogen Peroxide; Immunohistochemistry; Myocardium; Natriuretic Peptide, Brain; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Shal Potassium Channels; Time Factors; Ventricular Dysfunction; Ventricular Remodeling | 2011 |
Altered patterns of phosphorylation in cultured mouse lenses during development of buthionine sulfoximine cataracts.
Topics: alpha-Crystallin A Chain; Animals; Blotting, Western; Buthionine Sulfoximine; Cataract; Crystallins; Culture Techniques; Disease Progression; Electrophoresis, Gel, Two-Dimensional; Eye Proteins; Female; Intermediate Filament Proteins; Lens, Crystalline; Mass Spectrometry; Mice; Mice, Inbred Strains; Phosphorylation | 2002 |
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
Topics: Animals; Antioxidants; Brain; Buthionine Sulfoximine; Cystamine; Cysteine; Cytoprotection; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Female; Gene Expression Regulation; Glutathione; Humans; Huntington Disease; Male; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Peptides; Rats | 2004 |
Synergism of buthionine sulfoximine and melphalan against neuroblastoma cell lines derived after disease progression.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Buthionine Sulfoximine; Child; Disease Progression; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Melphalan; Neuroblastoma; Tumor Cells, Cultured | 2000 |